Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Preferred Dividend Payments (2021 - 2022)

Historic Preferred Dividend Payments for Prime Medicine (PRME) over the last 2 years, with Q4 2022 value amounting to $1.3 million.

  • Prime Medicine's Preferred Dividend Payments fell 7934.61% to $1.3 million in Q4 2022 from the same period last year, while for Sep 2023 it was $1.3 million, marking a year-over-year decrease of 9479.42%. This contributed to the annual value of $20.2 million for FY2022, which is 1683.06% up from last year.
  • Latest data reveals that Prime Medicine reported Preferred Dividend Payments of $1.3 million as of Q4 2022, which was down 7934.61% from $6.4 million recorded in Q3 2022.
  • Prime Medicine's Preferred Dividend Payments' 5-year high stood at $6.4 million during Q3 2021, with a 5-year trough of $1.3 million in Q4 2022.